By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Crescendo Biologics 

Meditrina Building 260
Babraham Research Campus
Cambridge    CB22 3AT  United Kingdom
Phone: 44-1223-497140 Fax: n/a



Start Up

Company News
Crescendo Biologics Appoints Dr Barbara Fleck As Head Of Intellectual Property 2/2/2016 9:34:10 AM
Crescendo Biologics Appoints Dr Kevin Johnson As Chairman 11/17/2015 11:01:23 AM
Crescendo Biologics Expands ADC Programmes With Innovate UK Funding Award 5/28/2015 8:15:26 AM
Crescendo Biologics To Present At Biotech Showcase™ 2015 1/6/2015 9:14:53 AM
Crescendo Biologics' Receives Further Investment From Astellas Venture Management To Develop Novel Humabody Therapeutics Targeting Immune Checkpoint Inhibitors 12/16/2014 8:02:39 AM
EMBL Ventures Invests £2M ($3.3M) In A Second Close Of Crescendo Biologics' Series A Financing 4/3/2014 9:20:31 AM
Crescendo Biologics Nabs $28 Million In Series A Financing 12/17/2013 8:01:48 AM
Crescendo Biologics Announces the Crescendo Mouse 1/16/2013 10:09:10 AM
Crescendo Biologics Release: Studies Show Vectra™ DA Multi-Biomarker Test Algorithm More Accurate than Other Established Disease Activity Measures in Identifying Rheumatoid Arthritis Patients at Risk for Joint Damage Progression 11/7/2011 6:31:09 AM
Crescendo Biologics Appoints Matthew Roe as Chief Business Officer 6/22/2011 6:43:37 AM